Ota Hidetaka, Yamaguchi Yasuhiro, Yamaguchi Kiyoshi, Eto Masato, Akishita Masahiro, Ouchi Yasuyoshi
Department of Geriatric Medicine, Graduate School of Medicine, The University of Tokyo.
Nihon Ronen Igakkai Zasshi. 2008 Jan;45(1):90-4. doi: 10.3143/geriatrics.45.90.
We report an 82-year old man prescribed paroxetine who had hyponatremia and in whom the syndrome of inappropriate secretion of antidiuretic hormone was diagnosed. He had taken sulpiride for depressed mental status. However, he showed parkinsonism, which was an adverse effect from the treatment of sulpiride. Therefore sulpiride was changed to selective serotonin reuptake inhibitor, paroxetine 10mg daily. His depressed mental status deteriorated after paroxetine treatment started. His depression had not lessened after 12 days, and the dosage was increased to 20mg daily. On the 15th day after starting paroxetine, routine laboratory tests showed that his serum sodium level was 126 mEq/l. We recognized that his confusion and loss of appetite were symptoms of hyponatremia, rather than of worsening depression. Laboratory data revealed hyponatremia, low serum osmolarity (242 mOsm/kg) with a relatively high level of serum antidiuretic hormone, and concentrated urine (439 mOsm/kg). We diagnosed the syndrome of inappropriate secretion of antidiuretic hormone (SIADH), associated with paroxetine. The dosage of paroxetine was reduced gradually and the serum sodium level returned to normal on day 2 after medication ceased completely. Paroxetine produces fewer adverse effects than other types of antidepressants. However, its use can be associated with inappropriate secretion of antidiuretic hormone in the body and may lead to SIADH, which is characterized by hyponatremia, a potentially fatal condition that is typically asymptomatic until it becomes severe. SIADH is more likely in some populations, including the elderly. Serum sodium levels should be monitored closely, especially in elderly patients.
我们报告了一名82岁的男性患者,他因服用帕罗西汀出现低钠血症,并被诊断为抗利尿激素分泌不当综合征。他曾因精神状态抑郁服用舒必利。然而,他出现了帕金森症,这是舒必利治疗的不良反应。因此,将舒必利换成了选择性5-羟色胺再摄取抑制剂,每日服用10mg帕罗西汀。开始服用帕罗西汀后,他的精神抑郁状态恶化。12天后他的抑郁症状并未减轻,于是剂量增加至每日20mg。开始服用帕罗西汀后的第15天,常规实验室检查显示他的血清钠水平为126mEq/L。我们认识到他的意识模糊和食欲不振是低钠血症的症状,而非抑郁症状加重。实验室数据显示低钠血症、血清渗透压降低(242mOsm/kg),同时血清抗利尿激素水平相对较高,尿液浓缩(439mOsm/kg)。我们诊断为与帕罗西汀相关的抗利尿激素分泌不当综合征(SIADH)。帕罗西汀的剂量逐渐减少,在完全停药后的第2天血清钠水平恢复正常。与其他类型的抗抑郁药相比,帕罗西汀产生的不良反应较少。然而,其使用可能与体内抗利尿激素分泌不当有关,并可能导致SIADH,其特征为低钠血症,这是一种潜在的致命疾病,在病情严重之前通常没有症状。SIADH在包括老年人在内的一些人群中更易发生。应密切监测血清钠水平,尤其是老年患者。